Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soft tissue sarcoma: advances in understanding and management.

M F Brennan1

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. brennanm@mskcc.org

The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|August 4, 2005
PubMed
Summary

Complete surgical resection is key for curing soft tissue sarcomas. While radiation and systemic therapies offer limited benefits for local or metastatic disease, targeted therapies show promise for future treatment advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staging of soft tissue sarcomas.

Annals of surgical oncology·1999
Same author

Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection.

Archives of surgery (Chicago, Ill. : 1960)·1999
Same author

Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma.

Archives of surgery (Chicago, Ill. : 1960)·1999
Same author

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.

Cancer·1999
Same author

Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery.

Annals of surgery·1999
Same author

Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.

Journal of the National Cancer Institute·1999

Area of Science:

  • Oncology
  • Surgical Pathology
  • Cancer Biology

Background:

  • Soft tissue sarcomas are rare, diverse neoplasms with varied prognoses.
  • Understanding their biology, distribution, and natural history is crucial.

Purpose of the Study:

  • To review recent advances in soft tissue sarcoma biology and natural history.
  • To emphasize predictive models for patient outcomes.
  • To highlight current and future therapeutic strategies.

Main Methods:

  • Comprehensive literature review of soft tissue sarcoma research.
  • Analysis of data on surgical resection, radiation therapy, and systemic therapy efficacy.
  • Evaluation of predictive models and emerging targeted therapies.

Related Experiment Videos

Main Results:

  • Complete surgical resection is the primary curative treatment.
  • Radiation therapy provides limited local disease control.
  • Systemic therapy offers minimal benefit for metastatic soft tissue sarcomas.

Conclusions:

  • Current treatments focus on complete resection for cure.
  • Targeted therapies utilizing specific molecular targets offer future hope for improved control and potential cure.
  • Further research into predictive models and targeted treatments is warranted.